6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one
C19H22ClN5O2 — CID 134794176
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one
6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one (PubChem CID 134794176) has the molecular formula C19H22ClN5O2 and a molecular weight of 387.87 g/mol. Its IUPAC name is 6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one.
Molecular Properties
| Compound Name | 6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one |
|---|---|
| PubChem CID | 134794176 |
| Molecular Formula | C19H22ClN5O2 |
| Molecular Weight | 387.87 g/mol |
| Exact Mass | 387.15 |
| IUPAC Name | 6-(4-chlorophenyl)-4-(4-hydroxypiperidin-1-yl)-9-methyl-5,8-dihydropyrimido[4,5-e][1,4]diazepin-7-one |
| SMILES | CN1CC(=O)N(c2ccc(Cl)cc2)Cc2c1ncnc2N1CCC(O)CC1 |
| InChI | InChI=1S/C19H22ClN5O2/c1-23-11-17(27)25(14-4-2-13(20)3-5-14)10-16-18(23)21-12-22-19(16)24-8-6-15(26)7-9-24/h2-5,12,15,26H,6-11H2,1H3 |
| InChIKey | PUEDRJIIEWNMHY-UHFFFAOYSA-N |
| XLogP | 2.07 |
| TPSA | 72.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.87 |
| LogP ≤ 5 | 2.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134794176 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.